
1. vaccine. 2006 apr 24;24(17):3440-5. epub 2006 feb 21.

boosting adenovirus-based vaccine improves protective efficacy against
venezuelan equine encephalitis virus following dna vaccination.

perkins sd(1), o'brien lm, phillpotts rj.

author information: 
(1)biomedical sciences department, defence science technology laboratory,
porton down, salisbury, wiltshire sp4 ojq, uk. sdperkins@dstl.gov.uk

there requirement vaccine protects alphavirus,
venezuelan equine encephalitis virus (veev). previous work shown dna
vaccines encoding structural proteins veev elicit immune responses and
protection veev though protection incomplete airborne
veev. study, demonstrate particle-mediated epidermal delivery 
a dna vaccine encoding e2 glycoprotein veev boosted a
mucosally-delivered ad-based vaccine encoding e2 glycoprotein. this
results improved th2-type igg response, increase neutralising
antibody significant increase protection airborne veev. this
indicates prime-boost may suitable immunisation regimen providing
protection airborne veev.

doi: 10.1016/j.vaccine.2006.02.020 
pmid: 16527377  [indexed medline]

